Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review

被引：17

作者：

Oostvogels, A. J. J. M. ^{[1
,2
]}

De Wit, G. A. ^{[1
,3
]}

Jahn, B. ^{[4
,5
]}

Cassini, A. ^{[6
]}

Colzani, E. ^{[6
]}

De Waure, C. ^{[7
]}

Kretzschmar, M. E. E. ^{[1
,3
]}

Siebert, U. ^{[4
,5
,8
,9
,10
]}

Muhlberger, N. ^{[4
]}

Mangen, M. -J. J. ^{[1
]}

机构：

[1] Univ Med Ctr Utrecht, Utrecht, Netherlands

[2] Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands

[3] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands

[4] UMIT Univ Hlth Sci, Med Informat & Technol, Dept Publ Hlth & Hlth Technol Assessment, Inst Publ Hlth Med Decis Making & Hlth Technol As, Vienna, Austria

[5] ONCOTYROL Ctr Personalized Canc Med, Div Hlth Technol Assessment & Bioinformat, Innsbruck, Austria

[6] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden

[7] Univ Cattolica Sacro Cuore, Inst Publ Hlth, I-00168 Rome, Italy

[8] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA

[9] Harvard Univ, MGH Inst Technol Assessment, Boston, MA 02115 USA

[10] Harvard Univ, Dept Hlth Policy & Management, Boston, MA 02115 USA

来源：

EPIDEMIOLOGY AND INFECTION | 2015年 / 143卷 / 09期

关键词：

Cost-effectiveness analysis; costs; disability-adjusted life years (DALYs); economic evaluation; infectious diseases; systematic review; PNEUMOCOCCAL CONJUGATE VACCINATION; COST-EFFECTIVENESS ANALYSIS; ROTAVIRUS VACCINATION; GLOBAL BURDEN; TRANSMISSION; PROGRAMS; QUALITY;

D O I：

10.1017/S0950268814001940

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

A systematic literature review was performed on full economic evaluations of infectious disease interventions using disability-adjusted life years (DALY) as outcome measure. The search was limited to the period between 1994 and September 2011 and conducted in Medline, SciSearch and EMBASE databases. We included 154 studies, mostly targeting HIV/AIDS and malaria with most conducted for African countries (40%) and <10% in high-income countries. Third-payer perspective was applied in 29% of the studies, 25% used the societal perspective and 12% used both. Only 16% of the studies took indirect effects (i.e. herd immunity) of interventions into account. Intervention, direct healthcare and indirect non-healthcare costs were taken into account in respectively 100%, 81% and 36% of the studies. The majority of the studies followed the Global Burden of Disease method for DALY estimations, but most studies deviated from WHO cost-effectiveness guidelines. Better adherence to freely accessible guidelines will improve generalizability between full economic evaluations.

引用

页码：1791 / 1802

页数：12

共 45 条

[41]

Tan-Torres Edejer T, 2003, MAKING CHOICES HLTH

[42] A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia [J].

Touch, Sok ;

Suraratdecha, Chutima ;

Samnang, Chham ;

Heng, Seng ;

Gazley, Lauren ;

Huch, Chea ;

Sovann, Ly ;

Chhay, Chab Seak ;

Soeung, Sann Chan .

VACCINE, 2010, 28 (29) :4593-4599

[43] Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil [J].

Vespa, Glaucia ;

Constenla, Dagna O. ;

Pepe, Camila ;

Safadi, Marco Aurelio ;

Berezin, Eitan ;

de Moraes, Jose Cassio ;

Herrerias de Campos, Carlos Alberto ;

Araujo, Denizar Vianna ;

de Andrade, Ana Lucia S. S. .

REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 26 (06) :518-528

[44]

Walker D, 2000, HEALTH ECON, V9, P681, DOI 10.1002/1099-1050(200012)9:8<681::AID-HEC545>3.0.CO

[45]

2-X

← 1 2 3 4 5 →